BIODESIGN HERNIA GRAFT G48216 C-SLH-8H-20X30

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2018-01-24 for BIODESIGN HERNIA GRAFT G48216 C-SLH-8H-20X30 manufactured by Cook Biotech.

Event Text Entries

[98123825] A review of the device lot history records indicated the device was manufactured to specifications. The deviation would not have contributed to the reported occurrence. A total of two (2) devices was produced from the lot. A review of the cbi complaint database did not reveal any additional complaints involving the reported lot number. A review of the ifu indicated that seroma formation and infection (irrespective of one another) are noted in the potential complications as some of the "possible adverse reactions with the use of any prosthesis. " in addition, the ifu notes that? Complications, such as delayed wound infection, premature degradation, hernia recurrence, bowel erosion, and the need for re-operation, should be reasonably expected in patients who are critically ill or who have severely contaminated abdomens. " the root cause of the seroma is likely related to the extensive disruption of tissue that occurred during the surgical procedure. However, seroma formation is a known inherent risk of the surgical procedure and is a known potential outcome with the use of any prosthesis.
Patient Sequence No: 1, Text Type: N, H10


[98123826] On (b)(6) 2017, dr. (b)(6) placed a c-slh-8h-20x30 in a (b)(6) male patient. The patient had a prior placement of polypropylene mesh which became infected. The infected polypropylene was removed by laparoscopy and the biodesign hernia graft was placed in an open procedure. The biodesign was placed for repair of a ventral hernia. Seroma fluid was drained for approximately 28-30 days. The patient was discharged from the hospital once the drain output was below 20 ml per day. Two (2) weeks later, approximately fifty (50) days post biodesign placement, the patient was admitted to the hospital due to fever and seroma formation. The seroma was unable to be drained due to thickness and the patient underwent additional surgery to assess for infection and seroma. The seroma was described as thick, 300 ml fluid collection, and a cause was unable to be found. A tissue specimen was sent for laboratory review.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1835959-2018-00002
MDR Report Key7214926
Report SourceDISTRIBUTOR
Date Received2018-01-24
Date of Report2018-02-12
Date Mfgr Received2018-02-06
Device Manufacturer Date2016-08-30
Date Added to Maude2018-01-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. PERRY GUINN
Manufacturer Street1425 INNOVATION PLACE
Manufacturer CityWEST LAFAYETTE IN 47906
Manufacturer CountryUS
Manufacturer Postal47906
Manufacturer Phone7654973355
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIODESIGN HERNIA GRAFT
Generic NameHERNIA GRAFT
Product CodeOXK
Date Received2018-01-24
Model NumberG48216
Catalog NumberC-SLH-8H-20X30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerCOOK BIOTECH
Manufacturer Address1425 INNOVATION PLACE WEST LAFAYETTE IN 47906 US 47906


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-01-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.